相关实验视频

Updated: Jan 15, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

汽车开辟道路:金属蛋白酶工程的汽车T细胞穿过固体瘤的道

Alessandro Gasparetto^1,2, Roberto Chiarle^1,2,3

¹Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.

Cancer immunology research

|October 8, 2025

概括

工程化基抗原受体 (CAR) T细胞重塑瘤微环境,改善它们透到固体瘤中. 这一策略在未临床模型中增强了CAR T细胞的功能,而不会增加毒性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

固体瘤在瘤微环境中存在物理障碍,阻碍了仿真抗原受体 (CAR) T细胞治疗的有效性.
固体瘤中的细胞外基质沉积阻碍了T细胞的透和功能.

研究的目的:

为了设计针对GD2的CAR T细胞,以克服瘤微环境障碍.
为了增强CAR T细胞透和固体瘤中的抗瘤活性.

主要方法:

用CAR T细胞进行基因工程,以表达矩阵金属蛋白酶7和骨质丁-b.
在临床前固体瘤模型中评估CAR T细胞透和功能.

主要成果:

改造的CAR T细胞表现出透瘤的增强能力,这些瘤具有密集的细胞外基质.
在临床前模型中观察到CAR T细胞功能改善.
在工程化CAR T细胞中没有检测到非标毒性增加.

结论:

工程CAR T细胞表达矩阵金属蛋白酶7和骨质丁-b是一种有前途的策略,以改善固体瘤的治疗.
具有细胞外矩阵重塑能力的CAR T细胞代表了癌症免疫疗法的潜在进步.

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...